MD2852B1 - Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacientii cu ciroza hepatica - Google Patents

Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacientii cu ciroza hepatica Download PDF

Info

Publication number
MD2852B1
MD2852B1 MDA20050089A MD20050089A MD2852B1 MD 2852 B1 MD2852 B1 MD 2852B1 MD A20050089 A MDA20050089 A MD A20050089A MD 20050089 A MD20050089 A MD 20050089A MD 2852 B1 MD2852 B1 MD 2852B1
Authority
MD
Moldova
Prior art keywords
budesonide
treatment
ascites
resistant
pacients
Prior art date
Application number
MDA20050089A
Other languages
English (en)
Other versions
MD2852C2 (ro
Inventor
Gheorghe Anghelici
Constantin Tabarna
Viorel Moraru
Larisa PROCOPISINA
Oleg Crudu
Original Assignee
Gheorghe Anghelici
Constantin Tabarna
Viorel Moraru
Larisa PROCOPISINA
Oleg Crudu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gheorghe Anghelici, Constantin Tabarna, Viorel Moraru, Larisa PROCOPISINA, Oleg Crudu filed Critical Gheorghe Anghelici
Priority to MDA20050089A priority Critical patent/MD2852C2/ro
Publication of MD2852B1 publication Critical patent/MD2852B1/ro
Publication of MD2852C2 publication Critical patent/MD2852C2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la medicina, in special la hepatologie. Esenta inventiei consta in utilizarea budesonidei pentru tratamentul ascitei rezistente la pacientii cu ciroza hepatica decompensata. Rezultatul inventiei consta in diminuarea procesului regional inflamator cronic prin micsorarea permeabilitatii peretelui vascular si a transsudarii lichidului in spatiul interstitial al organelor cavitatii abdominale si preintampina acumularea lui in cavitatea peritoneala, care duce la formarea ascitei rezistente.
MDA20050089A 2005-03-28 2005-03-28 Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică MD2852C2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050089A MD2852C2 (ro) 2005-03-28 2005-03-28 Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050089A MD2852C2 (ro) 2005-03-28 2005-03-28 Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică

Publications (2)

Publication Number Publication Date
MD2852B1 true MD2852B1 (ro) 2005-09-30
MD2852C2 MD2852C2 (ro) 2006-04-30

Family

ID=35057532

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050089A MD2852C2 (ro) 2005-03-28 2005-03-28 Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică

Country Status (1)

Country Link
MD (1) MD2852C2 (ro)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19742612A1 (de) * 1997-09-26 1999-04-01 Falk Pharma Gmbh Budesonid zur Behandlung von cholestatischen Lebererkrankungen
WO1999039699A1 (en) * 1998-02-09 1999-08-12 Rtp Pharma, Inc. Treatment of chronic inflammatory disorders of the gastrointestinal tract

Also Published As

Publication number Publication date
MD2852C2 (ro) 2006-04-30

Similar Documents

Publication Publication Date Title
DK3567619T3 (da) Korrosionsresistent permanent magnet og intravaskulær blodpumpe omfattende magneten
DK3535768T3 (da) Intravaskulær blodpumpe omfattende korrosionsresistent permanent magnet
IL291826B2 (en) Corrosion-resistant permanent magnet for intravascular blood pump
DK3990047T3 (da) Intravaskulær blodpumpe med flerlagede kerneløse spoler
DK3618884T3 (da) Blodpumpe med forstærket kateter
EP2578233A4 (en) THERAPEUTIC AGENT AGAINST PANCREAS CANCER
TR201818927T4 (tr) Kataterlerde İyileştirme
IL236356A0 (en) Use of iron citrate to treat patients with chronic kidney disease
EA201500552A1 (ru) Лечение релаксином одышки, ассоциированной с острой сердечной недостаточностью
TR200900200T2 (tr) Pıhtılaşmayı önleyici özelliklere sahip kalıcı kateter
IL245317A0 (en) Ferric citrate for reducing cardiac failure in chronic kidney disease patients
EA201071209A1 (ru) Применение дронедарона или его фармацевтически приемлемой соли для получения лекарственного средства для регуляции уровня калия в крови
EP2258374A4 (en) USE OF MASLINIC ACID FOR THE TREATMENT OF DISEASES AND THEIR SYMPTOMS THROUGH COX-2 INHIBITION
MD2852B1 (ro) Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacientii cu ciroza hepatica
FR3008317B1 (fr) Utilisation de microorganismes pour diminuer le taux de trimethylamine dans une cavite du corps humain, notamment pour le traitement de la trimethylaminurie ou d'une vaginose bacterienne et la prevention des maladies cardiovasculaires
MD2853C2 (ro) Utilizarea mesalazinei pentru tratamentul encefalopatiei portale în ciroza hepatică decompensată
MD3986B1 (ro) Utilizare a Diosminei pentru tratamentul gastropatiilor portale in ciroza hepatica
UA83408U (ru) Способ лечения больных хроническим панкреатитом при коморбидном течени/и ишемической болезни и синдроме хронической сердечной недостаточности
Kadakia et al. Pulmonary Empyema with Thoracic Compression resulting from Direct Invasion of Xanthogranulomatous Pyleonephritis
FR2974364B1 (fr) Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique
EP4482564A4 (en) BLOOD PUMP WITH CANBOARD IMPULSE
Wenzel et al. A52 PRECLINICAL TRIALS IN PULMONARY HYPERTENSION MODELS: NOVEL TARGETS AND DELIVERY: Inhibition Of Fatty Acid Amide Hydrolase (faah) Prevents Pulmonary Hypertension
PL120928U1 (pl) Prefabrykowany element modulowy komory grobowej
MD2873B1 (ro) Metoda de evaluare a starii circulatiei sanguine porto-hepatice la pacientii cu ciroza hepatica
RU2007140029A (ru) Способ лечения хронической сердечной недостаточности

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees